Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Advocacy, FDA autonomy, and CEO voice
John explains his public advocacy on policy issues, FDA authority, and why CEOs must speak up for science.
Play episode from 56:39
Transcript
